Joining some dots on the Oxford/AstraZeneca injection that is currently being litigated in the UK via the 1987 Consumer Protection Act
Following up yesterday’s article here:
Here are a few dots on the backstory of the Oxford/AstraZeneca C19 viral vector injection.
I was triggered by this comment from Dr Campbell’s cliff notes.
“Sir John Bell, Professor of medicine Oxford (Government’s chief adviser on life sciences) and adviser to the Joint Committee on Vaccination and Immunisation - AstraZeneca had become “really frazzled” - “They accept that their comms are a bit clunky, and they misjudged some things like clinical trials data and manufacturing, partly because they’ve not done a vaccine before.”
Read the last part of that last line again “.. they misjudged some things like clinical trials data and manufacturing, partly because they’ve not done a vaccine before.”
Uh huh. That completes the trifecta – Moderna or BioNTech had zero experience of a mass “vaccination” roll-out either.
Ok, first dot from here:
Interim analysis of the 4 randomised clinical trial results published in the Lancet here:
“.Overall vaccine efficacy across both groups was 70·4% - 30 [0·5%] of 5807 vs 101 [1·7%] of 5829.
Which is an Absolute Risk Reduction of 1.7% - 0.5% = 1.2% - z reduction of one case for every 100 cases encountered.
“175 severe adverse events occurred in 168 participants, 84 events in the ChAdOx1 nCoV-19 group and 91 in the control group.”
The advertising of “vaccine efficacy” related to C19 injections was always a fraud. It WAS NOT a clinical endpoint. Neither was hospitalisation or death. The sole clinical endpoint of the clinical trials was the reduction of severe symptoms.
Hence the amusement but irrelevance of this great video.
Video Clowns Fauci et al Over Rapidly Devolving Narrative on 'Vaccine' Effectiveness (noqreport.com)
All those statements in that video featuring Fauci are a blatant lie.
Severe adverse events were the primary end point of the Pfizer and Moderna clinical trials. The implication here is that the clinical end point for the Oxford/AstraZeneca vaccine was transmission and infection. Curious.
No reference to sample error/confidence interval of severe adverse events during the 3-4 months median follow-up period.
All from a manufacturer with zero experience in producing vaccines – no comment about that either.
Moving on, from here:
Research Alliance with Pfizer — University of Oxford, Medical Sciences Division
No indication of the amount given by Pfizer to Oxford University. I wonder what kind of collaboration was going on between the Pfizer mRNA and the Oxford University people.
COVID-19: The multi-billion pound business of the Oxford vaccine | Business News | Sky News
“A leading researcher on the vaccine insisted it was made not-for-profit during the pandemic, but could earn millions after.” Sounds just like a Gates business model.
Oxford University to build vaccines hub with £50m donation - BBC News
“A new Oxford University vaccine research building will be built following a £50m donation from an Indian-based vaccine developer. It will be in the new base for the Jenner Institute, which produced the Oxford-AstraZeneca Covid-19 vaccine.
Serum Life Sciences donated the money, in the university's biggest-ever single gift for vaccines research. The firm is owned by the Poonawalla family, which owns the Serum Institute of India.”
Oxford/AstraZeneca licensed the Serum Institute of India to distribute 1.75 billion doses supplied to the Government of India.
“The Serum Institute has supplied 1.75 billion doses out of 2.21 billion doses for all of India – almost 80%.”
There are no details on the license fees paid – Remember Moderna recently paid 400 million bucks in a “catch-up payment to Fauci’s NIAID. Fauci will get a cut of that and any other payments not subject to the “catch up”. Similar amounts will be coming back from the Serum Institute I would imagine. For ease, 1.75 billion bucks in license fees on the 1.75 billion doses equates to a license fee of a dollar a dose. Most governments paid around 20 bucks for the first monovalent Pfizer and Moderna doses.
Moderna pays NIAID $400M under new COVID vaccine license (fiercepharma.com)
Another dot:
“Less than 2% of the identified funding came from private industry, the researchers said, a finding they said posed a challenge to the views of people such as Boris Johnson, who has said that the record-fast development of Covid-19 vaccines was “because of capitalism, because of greed”.
Taxpayers and charitable foundations provided the majority of the funding for the Oxford/AstraZeneca vaccine identified by FOIs
UK government £38.8m
Overseas governments £26.2m
Charity £22.6m
PPP £13.2m
Industry £1.9m
Other £1.1m
The investigation has not been update that I could find. 95 million pound there. PPP = Public Private Partnership. Was the 22.6 million “charity” funding from the BMGF and the “industry” 1.9 million Pfizer?
Lots of dots there and here’s another blob rather than dot. Perhaps it provides even greater context by the time you get to the part on the ghost ship that has suborned the regulatory agencies.
There is a fantastic one hour interview on the appalling issues with the supply chain management involved with the roll-out of C19 injections here. In it, a four decades industry supply chain expert and pharma specialist, Hedley Rees, spells out in great detail how big pharma simply slaps its label in “product and little else. It does not manufacture, distribute or do any quality testing (neither do regulators).
Hedley has a SubStack that recently posted this:
(100) Key milestones in UK Government's excursion into gene therapy (substack.com)
“Oxford Biomedica (OXB) plants the seed”
“One highly effective approach to delivering the genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients cells.”
I understand that Oxford Biomedica is one of the manufacturers in the Oxford/AstraZeneca sC19 injection supply chain/
You can start a free 7 day trial to read the full article.
The rest of this article refers mainly to the C19 mRNA injections, especially Moderna.
Here is the link to the one hour podcast with Hedley. There is a full transcript available:
Medication Supply Chain Issues - Interview with Hedley Rees (medicaltruthpodcast.com)
Hedley Rees reveals the influence of Gates and the setting up of a fabricated from whole cloth regulatory body.
“Bill Gates hired the former chief executive of the Medicines and Healthcare Regulatory Agency in the UK. And he’s still, his name is Dr. Ian Hudson. He works for the Bill and Melinda Gates Foundation. He was also very senior at the European Medicines Agency.
Now, In 2016 this Ian Hudson set up a duplicate regulatory authority called the International Coalition for Medicines Regulatory Affairs. And he was the first chair. And you just have to Google it. If you Google it, I see MRA, you will find it. It was set up by the WHO initially in 2012 during a meeting in Brazil and every regulator in the world is a member of this duplicate body.”
That body has no legal authority to do anything. Those regulatory bodies participating are giving “ultra vires” powers to a cowboy outfit.
“.. big pharma companies had to buy the services of these companies to get the drugs developed and manufactured. And they were known companies, the largest in the world is a company called Lonza based in Switzerland, and it manufactures mainly biologics but also chemicals. And they actually made the Moderna drug substance. In Switzerland, we know that the other contract development of manufacturing organizations. The second biggest is Katlin Pharma Solutions. Which does the fill finished I mentioned for Moderna. So Moderna have outsourced all their drug development, manufacture, and distribution.
..
The FDA has enforcement powers to make companies remediate any issues that they find on inspections and yet And FDA have actually inspected two sites that are making the these injections. One is in Germany, a site, a company called Rensselaer. And the other one is Catlin Pharma Solutions, a company in Bloomington. And both those inspections, it’s on the internet, it’s public. FDA, all inspections go on the FDA website. The inspection report is called a form 483 and when you read those reports, they are horrible for the company. The FDA basically said the company wasn’t in control of what it was doing. It was shipping products, knowing that they were defective, but not recalling them. And anyone read it, you don’t have to be technical to read those reports and realize this is really very bad.”
I covered Hedley’s findings about Moderna here in Octobe 2022
(100) Recall of Moderna C19 Injections? - by Peter Halligan (substack.com)
Here is a link to the form 483 with these “Observations” on Moderna and FDA “Observations”:
download (fda.gov) (19 pages)
“OBSERVATION 1
Your firm failed to thoroughly investigate any unexplained discrepancy or failure of a batch or any of its components to meet any of its specifications, whether or not the batch has already been distributed.
OBSERVATION 3
Control procedures are not established which monitor the output and validate the performance of those manufacturing processes that may be responsible for causing variability in characteristics of the in-process material and the drug product.
OBSERVATION 4
Acceptance criteria for the sampling and testing conducted by the quality control unit is not adequate to ensure that batches of the drug product meet appropriate statistical quality control criteria as a condition for their approval and release.”
Back to more extracts from the Hedley Rees podcase:
“You’ve got all these companies in the supply chain. They’re different legal entities. They’ve got their own boards of directors. They don’t want to take any chances with anyone. So they’re all covering their backsides. They don’t want to get sued and they’re doing things that are totally against regulations. They’re not doing what they should do.
And we that we, we knew a batch was lost because of that. But there’ve been batches like emergent bio solutions and conflated two different batches. “
“AstraZeneca and Johnson mixed the two ones. Two. That is fundamentally bad. How can you mix up two separate companies orders and put them all together in the one? There is so many evidence in the supply chain, but inspectors aren’t going in to inspect these facilities, and if there’s one major opportunity that exists now, and FDA has started it with the two inspections that I mentioned, they should be going into the Pfizer plant in Andover, the YF Biopharma plant, the first plant that manufactured it. “
“The Pfizer injections, the emergency supplies, the 33 batches that have been associated with very high levels of adverse events. Now, I’ve looked at that company’s website. And it’s not a, it’s not a GMP compliance site. It’s an R and D site, a research and development site, right? They will not have the skills or the competency to manufacture the good distribution practice.
And if. If FDA went in there and inspected, they would see exactly what’s there and I’m a hundred percent certain they’ll say that company never was compliant, and these other companies are there waiting to be inspected and they’re not.”
Dot dot dot – dash dash dash – dot dot dot!
Onwards!
Please subscribe or make a donation via ko-fi. Don’t worry, if you can’t or don’t want to. Ko-fi donations here: https://ko-fi.com/peterhalligan - an annual subscription of 100 bucks is one third less than a $3 ko-fi donation a week!
There's that no.33 again.
As pandemic counter measures. No quality control was expected, and none was required.